glp-1 ras drugs 🔸 Should be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? “Perioperative Management of Patients Taking GLP-1 Receptor Agonists” explores Research shows GLP-1 receptor agonist

* Actual product received may vary slightly from the image shown

REIMAGINE 2 was a 68-week efficacy and safety phase 3 trial of CagriSema 2.4 mg/2.4 mg and 1 mg/1 mg once-weekly versus semaglutide 2.4 mg, semaglutide 1 mg, cagrilintide 2.4 mg, and placebo in 2,713 adults with type 2 diabetes inadequately controlled with metformin with or without an SGLT2 inhibitor

306 YuanY.ZhaH.RangarajanP.LingE.-A.WuC

Its healing benefits can be used on muscle tears, ligament and tendon damage, and even the nervous system

Research suggests that GLP-1 agonists may reduce the hedonic or reward-driven aspects of eating, not merely physiological hunger

Women use the same protocol